NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
1.190
0.00 (0.00%)
Dec 26, 2025, 4:00 PM EST - Market closed
NanoViricides Market Cap
NanoViricides has a market cap or net worth of $23.24 million as of December 26, 2025. Its market cap has increased by 9.60% in one year.
Market Cap
23.24M
Enterprise Value
22.11M
1-Year Change
9.60%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since September 25, 2013, NanoViricides's market cap has decreased from $293.90M to $23.24M, a decrease of -92.09%. That is a compound annual growth rate of -18.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 21.40M | 4.39% |
| Dec 31, 2024 | 20.50M | 70.83% |
| Dec 29, 2023 | 12.00M | -6.98% |
| Dec 30, 2022 | 12.90M | -69.93% |
| Dec 31, 2021 | 42.90M | 40.20% |
| Dec 31, 2020 | 30.60M | 215.46% |
| Dec 31, 2019 | 9.70M | -30.22% |
| Dec 31, 2018 | 13.90M | -75.04% |
| Dec 29, 2017 | 55.70M | -10.59% |
| Dec 30, 2016 | 62.30M | -8.38% |
| Dec 31, 2015 | 68.00M | -56.21% |
| Dec 31, 2014 | 155.30M | -35.32% |
| Dec 31, 2013 | 240.10M | -18.31% |
| Sep 25, 2013 | 293.90M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |